Headlines
- Construction proceeding on schedule at G2_Austin, timeline for production unchanged. Construction on the first 2.1 GW phase of T1’s flagship
U.S. solar cell fab, G2_Austin, is progressing according to plan. Since the start of construction in mid-December, T1 has together withYates & Sons Construction Company as the General Contractor, progressed construction to allow for the planned initiation of steel erection in April. Long lead items have been ordered, including the contract award to Laplace Renewable Energy Technology for turnkey delivery of the Production Line Equipment. By deploying cash from T1’s balance sheet in the initial stages of construction, the Company has reduced the remaining estimated capital spending for Phase 1 of G2_Austin to approximately$350 million . T1 remains on track to start of production for Phase 1 in the fourth quarter of 2026. - G1_Dallas quarterly production and sales set T1 record in Q4 2025. Achieved record quarterly module production for T1 of 1.13 GW, generating record net sales of
$358.5 million , in Q4 2025. The Company also added two large utility-scale customers to its merchant sales base during Q4, underscoring the commercial traction T1 is gaining from the successful ramp up of G1_Dallas. For the full-year 2025, T1 produced 2.79 GW at G1_Dallas, in line with previous guidance of 2.6 – 3.0 GW. - Capital formation initiatives advancing, targeting full financial close for G2_Austin early in Q2 2026. As previously disclosed, T1 has been pursuing a range of options to fund the remaining capital spending on the 2.1 GW Phase 1 of G2_Austin. During and subsequent to the fourth quarter, the Company has advanced potential funding pathways in the private and public markets on parallel tracks. With the equity capital T1 has already invested into construction of G2_Austin, the remaining Phase 1 funding requirement now stands at approximately
$350 million . T1 intends to select an optimal solution early in the second quarter to achieve full financial close.
“2025 was a defining year for
Board Updates
This morning, T1 announced that its board of directors (the “Board”) has elected
“As Founder and an early-stage investor in T1’s predecessor company, and later as a Board member,
“The Board also thanks
Highlights of Fourth Quarter 2025 and Subsequent Events
Treasury guidance supports T1’s tax credit eligibility. In February, T1 published a press release indicating that initialU.S. Treasury guidance on Foreign Entity of Concern (“FEOC”) restrictions was consistent with T1’s expectations and supportive of the Company’s analysis of its eligibility for Section 45X tax credits. The release followed several months of detailed compliance efforts, capital raising, debt repayment, intellectual property restructuring, and other key agreements, culminating in the series of transactions designed to secure compliance with FEOC requirements that we announced onDecember 30, 2025 .- Strategic transactions lay groundwork for T1 to deliver FEOC compliant solar modules to customers in 2026 and beyond. In December, T1 announced that the Company concluded a series of transactions with Trina Solar and other parties to allow T1 to continue its eligibility in 2026 for Section 45X tax credits. The transactions included debt repayment, removal of Trina’s right to appoint a covered officer, a new intellectual property licensing agreement with
Evervolt Green Energy Holding Pte Ltd. , and the purchase of solar cells from a supplier that provided certifications of its non-FEOC status. - T1 executes first sale of Section 45X tax credits. In December, T1 announced that it completed a
$160 million sale of Section 45X production tax credits (“PTCs”) to a leading, investment grade buyer of tax credits. T1 executed the Tax Credit Purchase and Sale Agreement in December at a price of$0.91 per dollar of PTC generated. - T1 and
Treaty Oak execute strategic partnership. In December, the Company announced that it signed a three-year contract to supply independent power producerTreaty Oak Clean Energy, LLC with a minimum of 900 MW of solar modules built with domestic solar cells from T1’s planned G2_Austin solar cell fab. - T1 starts construction on 2.1 GW Phase One of G2_Austin
U.S. solar cell fab. Following the Company’s capital formation activities in Q4 2025, T1 announced that construction began on its G2_Austin solar cell fab inDecember 2025 . Phase 1 of G2_Austin brings an anticipated$400 -$425 million capital investment in advanced American manufacturing and is part of T1’s ongoing commitment to building a strong domestic silicon-based manufacturing industry, bolstering American energy security and creating skilled American jobs. - T1 prices concurrent public offerings of convertible senior notes due 2030 and common stock. In
December 2025 , T1 announced the pricing of its previously announced underwritten public offerings of$161 million aggregate principal amount of its 5.25% convertible senior notes due 2030 and 32,525,254 shares of its common stock at a public offering price of$4.95 per share.
2026 – 2027 Business Outlook
- Maintaining 2026 production and sales guidance of 3.1 – 4.2 GW. T1 is sourcing cells during the 2026 bridge year to the expected start of G2_Austin production through international suppliers who have certified their non-FEOC status. In total, T1 plans to produce between 3.1 – 4.2 of modules at G1_Dallas in 2026 using cells sourced from an expanding global vendor network. As the Company continues to engage and qualify new suppliers to G1, T1 is increasingly confident in its ability to procure cells closer to the high-end of this targeted range.
- T1 has 3 GW of G1_Dallas production contracted for 2026. As previously disclosed, T1 has 3 GW of either cost plus or fixed margin G1 customer contracts in place for 2026. Additionally, the Company is monitoring a few significant swing factors that could materially impact 2026 sales, module pricing, earnings and cash flow. These factors include a potential ruling in the
U.S. Secretary of Commerce’s Section 232 investigation into foreign-sourced polysilicon; the potential to source third-party cells above the high-end of T1’s targeted range; and customer safe harboring activity as developers work within the new 2026 regulatory framework. T1 intends to provide detailed 2026 guidance as the potential range of outcomes for these swing factors narrows. - Maintaining integrated G1/G2 operating and financial guidance. There are no changes to T1’s annual run-rate Adjusted EBITDA guidance for the staged integrated production between G1_Dallas and G2_Austin. Upon completion of the first 2.1 GW phase of G2, T1 expects to generate annualized run-rate Adjusted EBITDA of
$375 -$450 million during 2027. Fully integrated production of 5 GW each between G1 and G2 is expected to produce an annualized Adjusted EBITDA run-rate of$650 -$700 million .
Q4 and Full-Year 2025 Results Overview
T1 Energy reported a net loss attributable to common stockholders for the fourth quarter of 2025 of$190.0 million , or$(0.87) per share, compared to a net loss of$367.2 million , or$(2.59) per share, for the fourth quarter of 2024. Net loss from continuing operations was$153.0 million , or$(0.70) per share, for the fourth quarter of 2025 compared to$30.8 million , or$(0.22) per share, for the fourth quarter of 2024. Net loss from discontinued operations was$36.1 million , or$(0.17) per share, for the fourth quarter of 2025 compared to$336.4 million , or$(2.37) per share for the fourth quarter of 2024.- For the full-year 2025 T1 reported a net loss attributable to stockholders of
$380.8 million , or$2.19 per diluted share, of which$0.26 per share was from discontinued operations, compared to a net loss for the full-year 2024 of$450.2 million , or$3.20 per diluted share, of which$2.72 per share was from discontinued operations. - As of
December 31, 2025 , T1 had cash, cash equivalents, and restricted cash of$270.8 million , of which$182.5 million was unrestricted cash.
Presentation of Fourth Quarter and Full-Year 2025 Results
A presentation will be held today,
Participants can access the conference call by clicking the following link and completing the online registration form. Upon registering participants will receive the dial-in info and PIN to join the call.
The call will also be available by clicking the webcast link.
About
To learn more about T1, please visit www.T1energy.com and follow on social media.
Investor contact:
EVP, Investor Relations and Corporate Development
jeffrey.spittel@T1energy.com
Tel: +1 409 599-5706
Media contact:
EVP,
russell.gold@T1energy.com
Tel: +1 214 616-9715
Cautionary Statement Concerning Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation with respect to T1’s strategy of developing as an integrated
T1 intends to use its website as a channel of distribution to disclose information which may be of interest or material to investors and to communicate with investors and the public. Such disclosures will be included on T1’s website in the ‘Investor Relations’ section. T1, and its CEO and Chairman of the Board,
Use of Non-GAAP Financial Measures
T1 reports financial results in accordance with generally accepted accounting principles in
T1 defines Adjusted EBITDA as net income (loss) from continuing operations before interest expense, income tax expense (benefit), depreciation and amortization, and further adjusted to exclude certain items that management does not consider indicative of the Company’s core operating performance, including, but not limited to, non-cash charges, non-recurring items, and non-operating gains or losses. These adjustments include impairment charges, losses on debt extinguishment, losses on settlement of derivative liabilities, share-based compensation, fair value adjustments of warrant and derivative liabilities, and non-recurring transaction expenses. Our Adjusted EBITDA measure was re-defined in the fourth quarter of 2025 to also exclude certain non-recurring transaction expenses. The historical presentation of Adjusted EBITDA in this press release has been recast to conform to the revised definition.
T1 uses Adjusted EBITDA as a key measure in evaluating its financial and operating performance and in making strategic business decisions. T1 believes that Adjusted EBITDA, when considered together with the corresponding GAAP financial measures, provides meaningful supplemental information by excluding items that may not be representative of its core business, operating results, or future outlook. However, Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) from continuing operations or any other measure of performance or liquidity presented in accordance with GAAP.
Adjusted EBITDA has been reconciled to the nearest GAAP measure for historical periods in the table entitled “Reconciliation of Non-GAAP Measures to Most Comparable Amounts” set forth on Annex A of this press release. However, T1 is unable to provide a reconciliation for the forward-looking Adjusted EBITDA guidance because it does not currently have sufficient information to accurately estimate all of the variables and individual adjustments for such reconciliation. As such, T1’s management cannot estimate on a forward-looking basis without unreasonable effort the impact these variables and individual adjustments will have on its reported results.
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except per share data) (Unaudited) | ||||||||
| 2025 | 2024 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 182,450 | $ | 72,641 | ||||
| Restricted cash | 81,203 | 4,004 | ||||||
| Accounts receivable trade, net - related parties | 84,481 | — | ||||||
| Government grants receivable, net | 36,376 | 687 | ||||||
| Inventory | 116,043 | 274,549 | ||||||
| Advances to suppliers | 137,532 | 164,811 | ||||||
| Other current assets | 5,989 | 4,370 | ||||||
| Current assets of discontinued operations | 19,418 | 50,959 | ||||||
| Total current assets | 663,492 | 572,021 | ||||||
| Restricted cash | 7,120 | — | ||||||
| Property and equipment, net | 302,302 | 293,633 | ||||||
| 57,449 | 74,527 | |||||||
| Intangible assets, net | 180,481 | 283,506 | ||||||
| Right-of-use asset under operating leases | 151,166 | 112,159 | ||||||
| Other assets | 10,098 | — | ||||||
| Total assets | $ | 1,372,108 | $ | 1,335,846 | ||||
| LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 91,323 | $ | 61,745 | ||||
| Accrued liabilities and other | 47,224 | 93,318 | ||||||
| Deferred revenue | 56,731 | 48,698 | ||||||
| Derivative liabilities | 11,661 | 14,905 | ||||||
| Current portion of long-term debt | 46,357 | 42,867 | ||||||
| Current portion of long-term debt - related party | — | 51,500 | ||||||
| Accounts payable and accrued liabilities - related parties | 162,754 | 52,534 | ||||||
| Current liabilities of discontinued operations | 47,538 | 44,557 | ||||||
| Total current liabilities | 463,588 | 410,124 | ||||||
| Long-term deferred revenue | 48,189 | 32,000 | ||||||
| Convertible note | 152,960 | — | ||||||
| Convertible note - related party | — | 80,698 | ||||||
| Operating lease liability | 143,534 | 105,687 | ||||||
| Long-term debt | 137,303 | 188,316 | ||||||
| Long-term debt - related party | 53,538 | 238,896 | ||||||
| Deferred tax liability | 3,758 | 21,227 | ||||||
| Other long-term liabilities | 47,353 | 21,761 | ||||||
| Total liabilities | 1,050,223 | 1,098,709 | ||||||
| Commitments and contingencies | ||||||||
| Redeemable preferred stock | ||||||||
| Convertible series A preferred stock, of 31, 2025, and accrued dividends and accretion of | — | 48,375 | ||||||
| Convertible series B preferred stock, as of December 31, 2025 and 2024, respectively) | 17,805 | — | ||||||
| Convertible series B-1 preferred stock, as of December 31, 2025 and 2024, respectively) | 53,710 | — | ||||||
| Equity: | ||||||||
| Common stock, December 31, 2025 and 2024, respectively | 2,663 | 1,559 | ||||||
| Additional paid-in capital | 1,358,992 | 971,416 | ||||||
| Accumulated other comprehensive loss | (18,213 | ) | (58,975 | ) | ||||
| Accumulated deficit | (1,093,072 | ) | (725,238 | ) | ||||
| Total equity | 250,370 | 188,762 | ||||||
| Total liabilities, redeemable preferred stock and equity | $ | 1,372,108 | $ | 1,335,846 | ||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (In thousands, except per share data) (Unaudited) | |||||||||||||||
| Three months ended | Year ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net sales | $ | 11,613 | $ | — | $ | 168,463 | $ | — | |||||||
| Net sales - related party | 346,941 | 2,942 | 586,832 | 2,942 | |||||||||||
| Total net sales | 358,554 | 2,942 | 755,295 | 2,942 | |||||||||||
| Cost of sales | 374,663 | 1,714 | 699,714 | 1,714 | |||||||||||
| Gross profit | (16,109 | ) | 1,228 | 55,581 | 1,228 | ||||||||||
| Operating expenses: | |||||||||||||||
| Selling, general and administrative | 66,306 | 30,604 | 235,316 | 79,196 | |||||||||||
| Impairment of intangible assets | 160 | 1,038 | 54,832 | 1,038 | |||||||||||
| Total operating expenses | 66,466 | 31,642 | 290,148 | 80,234 | |||||||||||
| Operating loss from continuing operations | (82,575 | ) | (30,414 | ) | (234,567 | ) | (79,006 | ) | |||||||
| Other (expense) income: | |||||||||||||||
| Warrant liability fair value adjustment | (11,224 | ) | (2,585 | ) | (8,356 | ) | (1,291 | ) | |||||||
| Derivative liabilities fair value adjustment | (26,632 | ) | (14,905 | ) | (31,223 | ) | (14,905 | ) | |||||||
| Loss on settlement of derivative liability | — | — | (5,836 | ) | — | ||||||||||
| Loss on debt extinguishment | (8,753 | ) | — | (8,753 | ) | — | |||||||||
| Impairment of assets previously classified as held for sale | (10,883 | ) | — | (16,057 | ) | — | |||||||||
| Interest (expense) income, net | (9,800 | ) | (234 | ) | (37,093 | ) | 3,393 | ||||||||
| Foreign currency transaction (loss) gain | 11 | 7 | (200 | ) | 563 | ||||||||||
| Other income, net | (1,971 | ) | 1,612 | 1,355 | 8,685 | ||||||||||
| Total other expense | (69,252 | ) | (16,105 | ) | (106,163 | ) | (3,555 | ) | |||||||
| Loss from continuing operations before income taxes | (151,827 | ) | (46,519 | ) | (340,730 | ) | (82,561 | ) | |||||||
| Income tax benefit | (1,203 | ) | 15,771 | 19,372 | 15,760 | ||||||||||
| Net loss from continuing operations | (153,030 | ) | (30,748 | ) | (321,358 | ) | (66,801 | ) | |||||||
| Net loss from discontinued operations, net of tax | (36,097 | ) | (336,399 | ) | (46,476 | ) | (383,753 | ) | |||||||
| Net loss | (189,127 | ) | (367,147 | ) | (367,834 | ) | (450,554 | ) | |||||||
| Net loss attributable to non-controlling interests | — | — | — | 402 | |||||||||||
| Preferred dividends and accretion | (910 | ) | (87 | ) | (3,511 | ) | (87 | ) | |||||||
| Preferred deemed dividend | — | — | (7,777 | ) | — | ||||||||||
| Tranche right deemed dividend | — | — | (1,667 | ) | — | ||||||||||
| Net loss attributable to common stockholders | $ | (190,037 | ) | $ | (367,234 | ) | $ | (380,789 | ) | $ | (450,239 | ) | |||
| Weighted average shares outstanding: | |||||||||||||||
| Weighted average shares of common stock outstanding - basic and diluted | 218,398 | 141,848 | 173,640 | 140,538 | |||||||||||
| Net loss per share attributable to common stockholders: | |||||||||||||||
| Net loss per share from continuing operations - basic and diluted | $ | (0.70 | ) | $ | (0.22 | ) | $ | (1.93 | ) | $ | (0.48 | ) | |||
| Net loss per share from discontinued operations - basic and diluted | $ | (0.17 | ) | $ | (2.37 | ) | $ | (0.26 | ) | $ | (2.72 | ) | |||
| Net loss per share - basic and diluted | $ | (0.87 | ) | $ | (2.59 | ) | $ | (2.19 | ) | $ | (3.20 | ) | |||
| Other comprehensive loss: | |||||||||||||||
| Net loss | $ | (189,127 | ) | $ | (367,147 | ) | $ | (367,834 | ) | $ | (450,554 | ) | |||
| Foreign currency translation adjustments | (2,407 | ) | (24,940 | ) | 40,762 | (40,149 | ) | ||||||||
| Total comprehensive loss | (191,534 | ) | (392,087 | ) | (327,072 | ) | (490,703 | ) | |||||||
| Comprehensive loss attributable to non-controlling interests | — | — | — | 402 | |||||||||||
| Preferred dividends and accretion | (910 | ) | (87 | ) | (3,511 | ) | (87 | ) | |||||||
| Preferred deemed dividend | — | — | (7,777 | ) | — | ||||||||||
| Tranche right deemed dividend | — | — | (1,667 | ) | — | ||||||||||
| Comprehensive loss attributable to common stockholders | $ | (192,444 | ) | $ | (392,174 | ) | $ | (340,027 | ) | $ | (490,388 | ) | |||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) | ||||||||
| Year ended | ||||||||
| 2025 | 2024 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (367,834 | ) | $ | (450,554 | ) | ||
| Adjustments to reconcile net loss to cash used in operating activities: | ||||||||
| Share-based compensation expense | 11,397 | 7,751 | ||||||
| Depreciation and amortization | 93,296 | 10,455 | ||||||
| Impairment of intangible assets | 54,832 | 1,038 | ||||||
| Impairment of assets previously classified as held for sale | 16,057 | — | ||||||
| Change in valuation allowance | 8,206 | 311,858 | ||||||
| Reduction in the carrying amount of long-term investments due to license termination | — | 21,028 | ||||||
| Change in fair value of derivative liabilities | 31,223 | 14,905 | ||||||
| Loss on debt extinguishment | 8,753 | — | ||||||
| Loss on settlement of derivative liability | 5,836 | — | ||||||
| Gain on sale of property and equipment | (5,675 | ) | — | |||||
| Amortization of debt issuance costs, premium and discount | 14,629 | — | ||||||
| Reduction in the carrying amount of right-of-use assets | 6,420 | 1,988 | ||||||
| Warrant liability fair value adjustment | 8,356 | 1,291 | ||||||
| Deferred income taxes | (13,995 | ) | (22,159 | ) | ||||
| Foreign currency transaction net unrealized loss (gain) | (303 | ) | (1,538 | ) | ||||
| Other | 4,325 | 1,434 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable trade, net - related parties | (77,214 | ) | — | |||||
| Government grants receivable, net | (35,689 | ) | — | |||||
| Inventory | 158,506 | — | ||||||
| Other assets | (5,088 | ) | — | |||||
| Advances to suppliers and other current assets | 19,519 | (7,885 | ) | |||||
| Accounts payable, accrued liabilities and other | 135,142 | 7,571 | ||||||
| Deferred revenue | 24,764 | — | ||||||
| Net cash provided by (used in) operating activities | 95,463 | (102,817 | ) | |||||
| Cash flows from investing activities: | ||||||||
| Proceeds from the return of property and equipment deposits | 1,202 | 22,735 | ||||||
| Purchases of property and equipment | (78,799 | ) | (50,830 | ) | ||||
| Proceeds from the sale of property and equipment | 50,000 | — | ||||||
| Purchase of equity investment | (5,000 | ) | — | |||||
| Business acquisition, net of cash acquired | — | (109,636 | ) | |||||
| Net cash used in investing activities | (32,597 | ) | (137,731 | ) | ||||
| Cash flows from financing activities: | ||||||||
| costs | 49,831 | 50,000 | ||||||
| Repayment of Senior Secured Credit Facility | (42,867 | ) | — | |||||
| Extinguishment of long-term debt - related party | (240,903 | ) | — | |||||
| Proceeds from issuance of Convertible Notes, net of underwriting fees | 154,157 | — | ||||||
| Payment of debt issuance costs | (8,090 | ) | — | |||||
| Payment for non-controlling interest | — | (4,130 | ) | |||||
| Equity-based compensation tax withholding | (101 | ) | — | |||||
| Proceeds from Common Stock Offering, net of underwriting fees | 151,743 | — | ||||||
| Proceeds from Registered Direct Offering, net of placement fees | 68,040 | — | ||||||
| Payment of costs related to equity offerings | (1,892 | ) | — | |||||
| Net cash provided by financing activities | 129,918 | 45,870 | ||||||
| Effect of changes in foreign exchange rates on cash, cash equivalents, and restricted cash | 1,344 | (4,419 | ) | |||||
| Net decrease in cash, cash equivalents, and restricted cash | 194,128 | (199,097 | ) | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | 76,645 | 275,742 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 270,773 | $ | 76,645 | ||||
| Reconciliation to consolidated balance sheets: | ||||||||
| Cash and cash equivalents | $ | 182,450 | $ | 72,641 | ||||
| Restricted cash | 88,323 | 4,004 | ||||||
| Cash, cash equivalents, and restricted cash | $ | 270,773 | $ | 76,645 | ||||
RECONCILIATION OF NON-GAAP MEASURES TO MOST COMPARABLE AMOUNTS (In thousands) (Unaudited) | |||||||||||||||
| Three months ended | Year ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net loss | $ | (189,127 | ) | $ | (367,147 | ) | $ | (367,834 | ) | $ | (450,554 | ) | |||
| Net loss from discontinued operations, net of tax | 36,097 | 336,399 | 46,476 | 383,753 | |||||||||||
| Net loss from continuing operations | (153,030 | ) | (30,748 | ) | (321,358 | ) | (66,801 | ) | |||||||
| Adjustments to decrease (increase) net loss from continuing operations | |||||||||||||||
| Interest expense (income), net | $ | 9,800 | $ | 234 | $ | 37,093 | $ | (3,393 | ) | ||||||
| Income tax expense (benefit) | 1,203 | (15,771 | ) | (19,372 | ) | (15,760 | ) | ||||||||
| Depreciation and amortization | 24,666 | 1,178 | 93,296 | 1,658 | |||||||||||
| Impairment of intangible assets | 160 | 1,038 | 54,832 | 1,038 | |||||||||||
| Impairment of assets previously classified as held for sale | 10,883 | — | 16,057 | — | |||||||||||
| Warrant liability fair value adjustment | 11,224 | 2,585 | 8,356 | 1,291 | |||||||||||
| Derivative liabilities fair value adjustment | 26,632 | 14,905 | 31,223 | 14,905 | |||||||||||
| Loss on settlement of derivative liability | — | — | 5,836 | — | |||||||||||
| Loss on debt extinguishment | 8,753 | — | 8,753 | — | |||||||||||
| Other (income) expense, net | 1,971 | (1,612 | ) | (1,355 | ) | (8,685 | ) | ||||||||
| Share-based compensation expense | 4,294 | 2,139 | 11,397 | 6,898 | |||||||||||
| Transaction and nonrecurring expenses(1) | 2,919 | 13,791 | 10,288 | 15,463 | |||||||||||
| Adjusted EBITDA | $ | (50,525 | ) | $ | (12,261 | ) | $ | (64,954 | ) | $ | (53,386 | ) | |||
(1) Transaction and nonrecurring expenses of
Source: 